Akeso Inc Investor Relations Material
Latest events
H2 2024
Akeso Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Akeso Inc
Access all reports
Akeso Inc is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of innovative therapies. The company focuses on oncology, immunology, and other therapeutic areas, utilizing its proprietary research platforms to develop monoclonal antibody drugs. The company is headquartered in Zhongshan, China, and its shares are listed on the SEHK.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
9926
Country
🇭🇰 Hong Kong